Clinical Trial Update: Prospective Single-Arm Clinical Trial of GO Regimen for HLH. [Phase 2, Phase 3]

View source ↗

Summary

A prospective single-arm Phase 2/Phase 3 clinical trial evaluating the GO regimen for hemophagocytic lymphohistiocytosis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophagocytic Lymphohistiocytosis

Drugs mentioned

• GO regimen

Snippet

Sponsor: Beijing Friendship Hospital | Conditions: Lymphohistiocytosis, Hemophagocytic | Phase 2, Phase 3 | Status: RECRUITING